CNS Disorders Conference | CNS Disorders Congress | Therapeutics | Moscow | Russia

Theme: Accelerate the Diagnosis, Prevention & Management of CNS Disorders

CNS Disorders 2022

Renowned Speakers

Dr Babak Kateb
Society for Brain Mapping & Therapeutics and Brain Mapping Foundation California
USA

Fabio Bianco
President and Chief Scientific Officer Neuro-Zone, Sanipedia Ltd Italy
Italy

Zhanna Semenova
Professor Clinical and Research Institute of Urgent Pediatric Surgery and Trauma
Russia

Sevinj Hamidova Abisalam
Director Stroke and Headache centers in Grand Hospital
Azerbaijan

CNS Disorders 2022

Dear Colleagues and Friends,

Greetings!

Conference Series welcomes you to join the CME and CPD Accredited: 7^th International Conference on Central Nervous System Disorders and Therapeutics during April 29-30, 2022 at Moscow, Russia.

The main theme of the conference is “Accelerate the Diagnosis, Prevention & Management of CNS Disorders”.

We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Neuroscience and Neurology.

CNS Disorders 2022 anticipates more than 300 partakers around the world with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates include Editorial Board Members of related to our International peer-reviewed journals.

This is an outstanding prospect for the delegates from universities and associations to network with the world class experts.

The intending members can confirm their involvement by registering for the meeting along with your contemporaries.

AVAIL EARLY BIRD OFFER.

Regards,
CNS Disorders 2022 Organizing Committee

Theme: Accelerate the Diagnosis, Prevention & Management of CNS disorders

On the behalf of Conference Series, It is our pleasure to invite you to Neurology conference entitled “7^th International Conference on Central Nervous System Disorders and Therapeutics” during April 29-30, 2022 at Moscow, Russia.

The main theme of our conference is "Accelerate the Diagnosis, Prevention & Management of CNS Disorders" which covers wide range of critically important sessions.

Overview of CNS Disorders:

A CNS disorder can upset either the spinal cord (myelopathy) or brain (encephalopathy), both of which are part of the central nervous system. The nervous system is vulnerable to various disorders. It can be impaired by the following trauma, infections, blood flow disruption, tumours, autoimmune disorders etc. Diseases of the central nervous system may involve the following:

Vascular Disorders: Stroke, Transient ischemic attack (TIA), Subarachnoid hemorrhage, Subdural hemorrhage and Hematoma, and Extradural haemorrhage
Infections: Meningitis, Encephalitis, and epidural abscess
Structural disorders: Brain or Spinal cord injury, Bell's palsy, Cervical spondylosis, Carpal tunnel syndrome, Brain or Spinal cord tumors
Functional disorders: Headache, Epilepsy, Dizziness, and Neuralgia
Degenerative disorders: Parkinson disease, Multiple sclerosis, Amyotrophic lateral sclerosis (ALS), Huntington chorea, and Alzheimer disease.

In addition, the geographical distribution of CNS disorder and market across the US, the top five countries of Europe and in Japan. The report also includes insights into the CNS disorder R&D product pipeline and explores the competitive landscape including major players in CNS disease market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in CNS disorder therapeutics market.

Why to attend?

CNS Disorders 2022 to bring together worldwide distinguished academics in the field of Neuro-oncologist, Neuropharmacology, Neurology, Neuropediatricians, Pediatric Oncologists, Neurosurgeons, Neurophysiologists, Neuroscience Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of CNS disorders to Patients.

Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery

The aim of the CNS Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

Target Audience

Directors, Head of Department, Professors, Industrial Researchers, Neuro-oncologist, Neuropediatricians, Neurophysiologists, Neurosurgeons, Neurologist, Neuroradiologist, Neuro-Pathologists, Rehabilitation Specialists , Nurses, Neuroscience Researchers and Students from academia in the research of CNS disorders.

Target Audience:

Academia: 65%
Industry: 25%
Others: 10%

Session 1: Central Nervous System Disorders

Central nervous system diseases, also known as central nervous system disorders, are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS)

Brain Dysfunction
Cerebellum: Aging and Cognitive Syndrome
Pathophysiology of CNS Disorders
White Matter Diseases
Hydrocephalus
Spinal Meningitis
Neuromyelitis Optica
Neuronal and Axonal Damages
Encephalitis
Case studies on Spinal Disorders
Arnold–Chiari Malformation
Functional and Structural Disorders
Fibromyalgia Syndrome
Cerebral Edema
Brain Infections and Abscess
Holoprosencephaly

Session 2: Cognitive Neuroscience

Cognitive neuroscience is the scientific field that is concerned with the study of the biological processes and aspects that underlie cognition, with a specific focus on the neural connections in the brain which are involved in mental processes. It addresses the questions of how cognitive activities are affected or controlled by neural circuits in the brain. Cognitive neuroscience is a branch of both neuroscience and psychology, overlapping with disciplines such as behavioural neuroscience, cognitive psychology, physiological psychology and affective neuroscience. Cognitive neuroscience relies upon theories in cognitive science coupled with evidence from neurobiology, and computational modelling.

Neurocognitive
Cognition Psychology
Evolution and Social Cognition
Cognitive Development
Methods of cognitive Neuroscience
Neurobehavioral and Cognitive Disorders
Cognitive Genomics & Behavioural Genetics
Cognitive Rehabilitation Therapy

Session 3: CNS and Neurosurgery

Most people think of neurosurgery as brain surgery — but it is much more!

It is the medical specialty concerned with the diagnosis and treatment of patients with injury to, or diseases/disorders of the brain, spinal cord and spinal column, and peripheral nerves within all parts of the body. The specialty of neurosurgical care includes both adult and paediatric patients. Dependent upon the nature of the injury or disease a neurological surgeon may provide surgical and/or non-surgical care.

Post-Surgical Neuralgias
Tumour and Metastatis
Current Neurosurgery Methods
Vascular Malfunctions and Surgery
Anatomical and Functional Neural Circuits
Neurosurgery Diagnostic Tests
Neuropathology

Session 4: Cerebral Disorders

Your brain is your body’s control centre. It’s part of the nervous system, which also includes the spinal cord and a large network of nerves and neurons. Together, the nervous system controls everything from your senses to the muscles throughout your body. When your brain is damaged, it can affect many different things, including your memory, your sensation, and even your personality. Brain disorders include any conditions or disabilities that affect your brain. This includes conditions that are caused by:

illness
genetics
traumatic injury

These disorders include epilepsy, Alzheimer disease and other dementias, cerebrovascular diseases including stroke, migraine and other headache disorders, multiple sclerosis, Parkinson's disease, neuro infections, brain tumours, traumatic disorders of the nervous system due to head trauma

Cerebral Hemorrhage
Hypertension
Cerebral Embolism
Cerebral Aneurysm
Stroke and Transient Ischaemic Attack
Vascular Malformation
Risk factors for Cerebrovascular Diseases
Epidemiology of Cerebrovascular Diseases
Technological Advances in Vascular Surgery

Session 5: Brain Tumour & Imaging

Diagnosing a brain tumour usually begins with magnetic resonance imaging (MRI). Once MRI shows that there is a tumour in the brain, the most common way to determine the type of brain tumour is to look at the results from a sample of tissue after a biopsy or surgery.

Neurology of Brain
Neuroimaging Software
Neuroradiology
Brain Imaging Techniques
Structural & Functional Imaging
Invasive and Non-Invasive Imaging of Tumour
Radiation & Chemotherapy
Pathophysiology of Brain Tumours
Neurobiology of Tumours
Novel Treatment Strategies

Session 6: Spinal Cord and Disorders

Spinal cord disorders can cause permanent severe problems, such as paralysis or impaired bladder and bowel control (urinary incontinence and fecal incontinence). Sometimes these problems can be avoided or minimized if evaluation and treatment are done quickly. Causes of spinal cord disorders include injuries, infections, a blocked blood supply, and compression by a fractured bone or a tumour. Typically, muscles are weak or paralyzed, sensation is abnormal or lost, and controlling bladder and bowel function may be difficult. Doctors base the diagnosis on symptoms and results of a physical examination and imaging tests, such as magnetic resonance imaging.

Arachnoiditis
Spinal Disorders Test
Spine Tumours
Transverse Myelitis
Syringomyelia
Spina Bifida
Spinal stroke
Scoliosis Spine
Sciatica
Spinal Stenosis
Cauda Equina Syndrome
Therapeutic Approaches for Spinal Disorders

Session 7: Neurodegenerative Disorders

Neurodegenerative disorders encompass a wide range of conditions that result from progressive damage to cells and nervous system connections that are essential for mobility, coordination, strength, sensation, and cognition. Neurodegenerative diseases affect millions of people worldwide. Although there isn’t a complete cure for most of these complex neurological diseases

Alzheimer Disease
Neuroinflammation Diseases
Werdnig-Hoffmann Disease
Prion disease
Amyotrophic Lateral Sclerosis Disease
Migraine and Headaches
Autism
Schizophrenia
Frontotemporal Lobar Degeneration
Multiple Sclerosis Disease
Parkinsonism
Huntington Disease

Session 8: Child Neurology

Child neurology, also known as paediatric neurology, specializes in the diagnosis and management of neurologic conditions during the neonatal period, infancy, early childhood, and adolescence. Child neurologists have special competence in the genetic and metabolic problems, malformations, and developmental problems of childhood, including epilepsy, cerebral palsy, muscular dystrophy, mental retardation, autism, Tourette's syndrome, Batten's disease, neurofibromatosis, learning disabilities, complex metabolic disorders, and a host of nerve and muscle diseases. Child neurologists act as consultants to primary care physicians as well as provide continuing care for chronic neurological conditions. Like other paediatric specialties, it is a specialty that requires the ability to work with patients who may have limited or non- existent verbal skills.

Congenital Hydrocephalus
Clinical Trials for Paediatric Epilepsy
Paediatric Neurology Practice
Paediatric Vestibular Disorders
Paediatrics Tumours
Attention Deficit Hyperactivity Disorder (ADHD)
Neural Rube Defects
Hereditary Ataxy
Neonatal Encephalopathy
Advance treatment of Paediatric Neurological Disorders

Session 9: Neuroimmunology

Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis, and response to injuries.

Epigenetics of Neuroimmunology
Paediatric Neuro-immunology
Neuroimmuno Genetics
Neurodevelopmental Diseases and Thermogenesis
Autoimmune Neuropathies
Antibody-mediated Disorders
Neuroimmunology Test
Psychoneuroimmunology
Neuromics, Neuroproteomics, Neurogenomics and Human Brain Proteome

Session 10: Neuropharmacology

Neuropharmacology is a branch of study which deals with drugs that affect the nervous system. It is focused on the development of compounds that may be of benefit to individuals who suffer from neurological or psychiatric illness. Neuropharmacology itself came into existence only five decades ago, prior to which there were only four drugs available for nerve disorders: morphine, caffeine, nitrous oxide, and aspirin. In the next 50 years, a new set of drugs such as antihistamines, barbiturates, and opioid analogs have emerged.

Molecular and Behavioural Neuropharmacology
Neuroethics
Available Therapeutics
Neural Circuits Regulating Appetite
Clinical Pharmacists
Surgical Aggression and Anesthesia
Physical Therapy
Antipsychotic drugs/ Neuroleptics
Clinical Neuropharmacology
Future Aspects of Neuropharmacology

Session 11: Neurochemical Transmission

Regardless of the type of neuron under consideration, the fundamental steps in chemical transmission are the same. Each of these steps is a potential site for pharmacological intervention in the normal transmission process:

1. Synthesis of the transmitter

2. Storage of the transmitter

3. Release of the transmitter by a nerve action potential

4. Interaction of the released transmitter with receptors on the effector cell membrane and the associated change in the effector cell

5. Rapid removal of the transmitter from the vicinity of the receptors

6. Recovery of the effector cell to the state that preceded transmitter action

Dopamine
Interneurons: Coordinators of Neuronal Synchrony
Advances in Astrocyte-Neuron Interactions in Health and Disease
Neurotransmission Receptors
Chemical Neurotransmitters
Human Synapses
Monoamines
Neuropeptides
Serotonin
Drug interaction in Various Stages in Neurotransmitters

Session 12: Novel Drug Development & its Effects

The Novel Drug Discovery Program focuses on activity guided isolation and structure elucidation of bioactive compounds from natural sources with high throughput screening. The program includes synthesis of bioactive compounds, analogues and internal standards for further drug development and bioavailability studies. Novel therapies are therapies entirely new to veterinary medicine either because they are genuinely novel and have not been previously used in the context of a medicine, or new only to the veterinary domain, although well known in terms of research, and possibly in the context of human medicine.

Anti-Neurodegenerative Drug Discovery
Nanoparticles as Drug Carriers
Role of Drug Metabolism in Drug Development
Enzyme Kinetics
Metabolism Mediated Drug-Drug Interactions
Blood Brain Barrier (BBB)
Centrally Acting Analgesics
Neurotransmitters, Neuromodulators, and Neuroreceptors
Neural Stem Cells and Gene or Cell Therapy
Ion Channels, Transporters and Neurotransmitter Receptors
Neurological Drug Targets

Session 13: Computational Neurosciences

Computational neuroscience (also known as theoretical neuroscience or mathematical neuroscience) is a branch of neuroscience which employs mathematical models, theoretical analysis and abstractions of the brain to understand the principles that govern the development, structure, physiology and cognitive abilities of the nervous system. Computational neuroscience involves studying brain function through computer modeling and mathematical analysis. Computational neuroscientists perform research in which they collect data and create computer models based on the electrical patterns and biological functions of the brain.

Neuroinformatics
Neural Science and Behaviour
Computational Drug Response Models
Neural Network Theory & Models
Neural Network Applications
Neuro Engineering

Session 14: Case Study on CNS

The CNS consists of the brain and spinal cord. The brain is protected by the skull (the cranial cavity) and the spinal cord travels from the back of the brain, down the centre of the spine, stopping in the lumbar region of the lower back. The brain and spinal cord are both housed within a protective triple-layered membrane called the meninges. The central nervous system has been thoroughly studied by anatomists and physiologists, but it still holds many secrets; it controls our thoughts, movements, emotions, and desires. It also controls our breathing, heart rate, the release of some hormones, body temperature, and much more. The retina, optic nerve, olfactory nerves, and olfactory epithelium are sometimes considered to be part of the CNS alongside the brain and spinal cord. This is because they connect directly with brain tissue without intermediate nerve fibres.

Case Studies Related to CNS Disorders
Case Studies on Child Neurology
Case Studies on Neuroimmunology
Case Studies on Neuro-Oncology
Case Reports on Brain Tumour
Case Studies on Cerebrovascular Disorders
Case Reports Related to Neuroimmunology Diseases

Session 15: Clinical Trials on CNS

CNS clinical trials bring specific challenges, including managing placebo response, incorporating soft endpoints, and require a particular focus on reducing patient burden. Unsurprisingly this had led to a challenging of accepted and established norms by CNS drug developers.

Alzheimer’s Disease and Cognition Clinical Trial
Neurology Clinical Trial
Pain Management and Analgesia Clinical Trial
Psychiatry Clinical Trial

Session 16: CNS Biomarkers

Biomarkers provide detailed measures of abnormal changes in the brain, which can aid in early detection of possible disease in people with very mild or unusual symptoms. People with Alzheimer's disease and related dementias progress at different rates, and biomarkers may help predict and monitor their progression.

Neuroimaging Enrichment for CNS Disease
CNS Drug Development Using Biomarkers
Cerebro Spinal Fluid Biomarkers
Biomarker Challenges in Rare Diseases

Session 17: Neurological Nursing

Neuroscience nurses care for people with a variety of neurological conditions and disorders across the lifespan and in all health care settings. There are many specialities encompassed within this field of practice. Most people with long-term neurological conditions live active and fulfilling lives and are cared for out of hospital, but may require admission to hospital for reasons that may or may not be related to their disorder. Many people will be supported by a specialist nurse and nursing team during their hospital stay.

Advance Practice Nursing
Acute Ischemic Stroke Patients
Paediatrics Nursing
Neuroscience Nursing
Trauma & Critical Care Nursing

Session 18: MOG antibody disease (MOGAD)

MOG antibody disease (MOGAD) is a recently coined neuro-inflammatory condition that preferentially causes inflammation in the optic nerve but can also cause inflammation in the spinal cord and brain. Myelin oligodendrocyte glycoprotein (MOG) is a protein that is located on the surface of myelin sheaths in the central nervous system. While the function of this glycoprotein is not exactly known, MOG is a target of the immune system in this disease. The diagnosis is confirmed when MOG antibodies in the blood are found in patients who have repeated inflammatory attacks of the central nervous system.

Neuromyelitis Optica Spectrum Disorder (NMOSD)

Transverse Myelitis (TM)

Acute Disseminated Encephalomyelitis (ADEM)

Optic Neuritis (ON)

Session 19: Neuro-Oncology

Neuro-oncology is a unique, developing neurologic subspecialty that combines many aspects of neurology with those of cancer biology. The neuro -oncologist is expert in both the diagnosis and management of primary brain tumors and neurologic complications of cancer. A career in neuro-oncology presents opportunities to utilize a multidisciplinary team approach and the application of cutting-edge technology toward patient treatment while providing compassionate patient care. Neuro-oncology can trace its modern origins to the 1970s, when the first therapeutic trials were begun. The treatment and management of primary brain Tumors is now a rapidly evolving field.

Tumors

Malignant brain cancers

CNS Disorders 2022 welcomes attendees, presenters, and exhibitors from all over the world to Moscow, Russia. We are delighted to invite you all to attend and register for the “7^th International Conference on Central Nervous System Disorders and Therapeutics” which is going to be held during April 29-30, 2022 in Moscow, Russia.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world.

We invite you to join us at the CNS Disorders 2022, where you will be sure to have a meaningful experience with scholars from around the world. All members of the CNS Disorders Congress organizing committee look forward to meeting you in Moscow, Russia.

For more details please visit- https://cns.global-summit.com/

Importance and Scope:

CNS Disorders Conference is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of CNS Disorders 2022.Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about CNS Disorders 2022 and its allied areas.

Why Russia?

Moscow is the most populated city in the Russia with residents of 2.2 million. Moscow is global business city and cultural hub of the Russia. It is one of the countries which has international network of research with higher-education Institutions, transport, business, communication, events and conference hub bridging healthcare professionals from the seven continents annually to collaborate and exchange knowledge and research.

Moscow's attraction lies in the contrast between the ultra-modern and the enchantingly traditional, which gives the city a personality like no other and visitors a variety of experiences to choose from. From top-class shopping opportunities, avant-garde architecture and the finest international cuisine, Moscow has more than enough depth to satisfy even the most seasoned of travellers.

Moscow is an upcoming global leader in medical innovation and research. About $177.5 million revenue generated from medical tourism in 2018, which may rise to $710 million by 2022-25. The medical tourism is expected to attract more than 500,000 patients per year and boost its economy by up to $2.6 billion by 2025.

Conference Highlights:

Central Nervous System disorders
Cognitive Neuroscience
Neurosurgery
Cerebrovascular Disorders
Brain Tumour and Imaging
Spinal Disorders
Neurodegenerative Disorders
Child Neurology
Neuroimmunology
Neuropharmacology
Neurochemical Transmission
Novel Drug Development & its Effect
Computational Neurosciences
Case Study on CNS
Clinical Trials on CNS
CNS Biomarkers
Neurological Nursing

Major Associations around the Globe

Brain Injury Association of America
The Brain and Behaviour Research Foundation
Alzheimer's Association
American Parkinson Disease Association
World Federation for Mental Health
British Neuro-oncology Society

Market Analysis Report:

The CNS disorders market may be segmented into numerous subcategories, including Alzheimer's disease (AD), epilepsy, insomnia, major depressive disorder (MDD), Parkinson's disease (PD), migraine, schizophrenia, attention-deficit hyperactivity disorder (ADHD), bipolar disorder among others. Antipsychotics were the largest CNS drug class. Patent expirations of key brands Seroquel and Zyprexa will form the main resistors to segmental growth through 2016.
In 2013-14 Alzheimer’s Research UAE spent approx. £8.7m on research projects. They focused projects into Alzheimer’s and dementia types such as vascular dementia frontotemporal dementia and Lewy bodies dementia.
The Global Acute Ischemic Stroke (AIS) market predicted an increase in rate of stroke market growth of 3.4 % from $2.9 billion in 2008 to $3.6 billion by 2015.
Brain Research through Advancing Innovative neuroethologies is a research effort launched by the Obama Administration to map the human brain working. In FY 2014, a $100 million fund was issued in name of the National Institutes of Health.
The Human Brain Project is the one of the longest running project; the project cost is estimated at 1.19 billion euros and planned to last ten years (2013-2023).
Parkinson Society Canada, Funding: $1,628,076, Duration: December 1, 2009 - March 31, 2014.
Millennium Research Group reported in January 2014 the global market for spinal non fusion will nearly triple in size through 2022. It is expected to surpass $1.6 billion, driven by the emerging Asia Pacific, Brazil, India and China markets. The Asia Pacific spinal implant and bone growth substitute market is projected to reach $7 billion by 2022, according to a Decision Resources Group report.

Major Organizations Dealing with Central Nervous System Disorders around the World

American Association of Neurological Surgeons
British Paediatric Neurology Association
National Institute-Neurological
American Academy of Neurology
European Neurological Societies
World Federation of Neurology
Spanish Society of Neurology
Neuro-Developmental Treatment Association

Universities working on Central Nervous System disorders in Worldwide

Stanford University
University of California
University of South Carolina Beauport
University of Helsinki
California Institute of Technology
Yale University
Harvard University
University of Pennsylvania
University of Chicago
The Kavli Institute for Brain Science
Cornell University
Johns Hopkins University
North-western University
Sydney Medical School
Institute for Stroke and Dementia Research, Munich
The Ohio State University

Hospitals treating Central Nervous System Disorders across the Globe

Cleveland Clinic
St Jude Children's Research Hospital
Johns Hopkins Medicine
Mayo Clinic Scottsdale AZ
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Centre
New York Presbyterian / Lower Manhattan Hospital
Deer's Head Hospital Centre
Montreal Neurological institute and Hospital
St George’s Hospital

Societies Associated with Central Nervous System Disorders in World

American Society of Neuro-rehabilitation, USa
Albanian Alzheimer Society
International Brain Research organization (IBRO)
Stroke Society of Australasia - AUSTRALIA
National Brain Tumour Society
Canadian Stroke Consortium - CANADA
The Chinese Stroke Association (CSA) – CHINA
The Japan Stroke Society – JAPAN
British Neuro-Oncology Society
Romanian National Stroke Association – ROMANIA
European Stroke Organization – SWITZERLAND
National Multiple Sclerosis Society
International Parkinson and Movement Disorders Society – USA

Companies Associated With Central Nervous System Disorders and Therapeutics Research in World

Abbott Laboratories
Cordis Corporation
Boston Scientific Corporation
Genentech, Inc.
Innovative NeuroTechnologies
Medtronic plc
GE Healthcare
Stryker Corporation
Medivation
Impax labs
NeuroNascent
Genzyme
AstraZeneca
Forest Laboratories
Chelsea Therapeutics
NeuroWave Systems
Serina Therapeutics

6^th International Conference on Central Nervous System Disorders and Therapeutics
August 31-01, 2020 London, UK
URL: https://cns.insightconferences.com/2020/#

5^th International Conference on Central Nervous System Disorders and Therapeutics
October 21-22, 2019 Lasvegas, USA
URL: https://cns.insightconferences.com/2019/#

4^th International Conference on Central Nervous System Disorders and Therapeutics
November 12-13, 2018 Edinburgh, Scotland
URL: https://cns.insightconferences.com/2018/#

3^rd International Conference on Central Nervous System Disorders and Therapeutics
Oct 02-03, 2017 Vienna, Austria
URL: https://cns.insightconferences.com/2017/#

2^nd International Conference on Central Nervous System Disorders and Therapeutics
December 05-07, 2016 Dubai, UAE
URL: https://cns.insightconferences.com/2016/#

Group Discounts Available

CNS Disorders 2022 is pleased to offer special rates to groups of 3 or more attending the 7^th International CNS Disorders and Therapeutics Conference from the same organization.

No of Attendees	EARLY BIRD REGISTRATION	LATE REGISTRATION
No of Attendees	Before Oct 30, 2021	Before Nov 15, 2021
Group : 3 - 5	$599	$649
Group : 6 - 10	$499	$549
Group : 10 & above	$399	$449
**Note: the above-mentioned price includes registrations charges only.

To register your group, please submit the attendee’s information via email to helpdesk@eventcontact.org or WHATSAPP us at +44-7868811437.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	April 29-30, 2022
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

7^th International Conference on Central Nervous System Disorders and Therapeutics April 29-30, 2022 Moscow, Russia

Recommended Global Medical Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links